A preclinical study utilizing the VEGF165 and VEGF121 growth factor, the active soluble secreted VEGF isoforms, radio iodinated with 123I found the radiolabeled agent can bind to human umbilical vein endothelial cells as well as a range of established tumor cell lines. The gene discussed is VEGFA; the disease is neoplasm.